Assessment of Quality of Life in Hemophiliac Patients
NCT03159663 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-05-23
Summary
Hemophilia is an X-linked congenital bleeding disorder caused by deficiency of coagulation factor VIII (in hemophilia A) or factor IX (in hemophilia B).
The deficiency is the result of mutations of the respective clotting factor genes.
Conditions
- Improvement of Quality of Life of Hemophiliac Patients
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 10 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2017-06-01
- Completion
- 2018-07-01
Countries
- Egypt
Study Locations
More Related Trials
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Comparison of Pulmonary Function, Exercise Capacity, and Physical Activity Level Between Children With Hemophilia and Healthy Controls
NCT06636565 ·Status: COMPLETED
-
Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
NCT01571934 ·Status: COMPLETED
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED
-
Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia
NCT03299699 ·Status: COMPLETED
-
Emotions in the Communication and Relationship Styles of Parents With Hemophilic Children.
NCT05754619 ·Status: UNKNOWN
-
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
NCT02971930 ·Status: COMPLETED
-
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
NCT00927667 ·Status: COMPLETED ·Phase: PHASE4
-
Chronic Pain and Hemophilia
NCT05202951 ·Status: RECRUITING
-
Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype
NCT03946384 ·Status: UNKNOWN
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
NCT03287999 ·Status: UNKNOWN
-
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027 ·Status: COMPLETED
-
Quality of Life Study of Helixate NexGen
NCT01053715 ·Status: COMPLETED
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab
NCT06104826 ·Status: NOT_YET_RECRUITING
-
Genetic Susceptibility to Factor VIII Inhibitors
NCT00344435 ·Status: COMPLETED
-
Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A
NCT02280265 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Gaining Insight Into the Complexity of Pain in Patients With Haemophilia
NCT05606640 ·Status: COMPLETED
-
Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia
NCT02108132 ·Status: UNKNOWN ·Phase: PHASE1
-
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
NCT03276130 ·Status: COMPLETED
-
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
NCT02197611 ·Status: UNKNOWN
-
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
NCT01988532 ·Status: COMPLETED
-
Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient
NCT04618237 ·Status: UNKNOWN